Cargando…

Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice

INTRODUCTION: The angiotensin II type 1 receptor (AT1R) and the peroxisome proliferator-activated receptor γ (PPARγ) have been implicated in the pathogenesis of atherosclerosis. A number of studies have reported that AT1R inhibition or genetic AT1R disruption and PPARγ activation inhibit vascular in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiyerili, Vedat, Becher, Ulrich M., Camara, Bakary, Yildirimtürk, Cihan, Aksoy, Adem, Kebschull, Moritz, Werner, Nikos, Nickenig, Georg, Müller, Cornelius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Experimental Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548041/ https://www.ncbi.nlm.nih.gov/pubmed/26322101 http://dx.doi.org/10.5114/aoms.2015.53309

Ejemplares similares

AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ
por: Tiyerili, Vedat, et al.
Publicado: (2013)

Atheroprotective effects of 17β-oestradiol are mediated by peroxisome proliferator-activated receptor γ in human coronary artery smooth muscle cells
por: Jehle, Julian, et al.
Publicado: (2020)

Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1(−/−) LDLr(−/−) double knockout mice
por: Jehle, Julian, et al.
Publicado: (2017)

Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype
por: Aksoy, Adem, et al.
Publicado: (2021)

CHA(2)DS(2)-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
por: Kavsur, Refik, et al.
Publicado: (2021)

Personalized cardiac regeneration by stem cells–Hype or hope?
por: Becher, Ulrich Marc, et al.
Publicado: (2011)

Sodium thiocyanate treatment attenuates atherosclerotic plaque formation and improves endothelial regeneration in mice
por: Zietzer, Andreas, et al.
Publicado: (2019)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

Propensity-score-matched comparison of safety, efficacy, and outcome of intravascular lithotripsy versus high-pressure PTCA in coronary calcified lesions
por: Aksoy, Adem, et al.
Publicado: (2021)

The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase
por: Zhang, Dapeng, et al.
Publicado: (2020)

A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens
por: Öztürk, Can, et al.
Publicado: (2021)

Myeloid But Not Endothelial Expression of the CB2 Receptor Promotes Atherogenesis in the Context of Elevated Levels of the Endocannabinoid 2-Arachidonoylglycerol
por: Avraamidou, Elina, et al.
Publicado: (2022)

The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation
por: Öztürk, Can, et al.
Publicado: (2020)

Citreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction
por: Hou, Hai-Feng, et al.
Publicado: (2015)

Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice
por: Hoyer, Friedrich Felix, et al.
Publicado: (2012)

The impact of peroxisome proliferator‐activated receptor‐γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy
por: Chiang, Cho‐Han, et al.
Publicado: (2023)

ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling
por: Al Zaidi, Muntadher, et al.
Publicado: (2022)

Hospital admissions during Covid-19 lock-down in Germany: Differences in discretionary and unavoidable cardiovascular events
por: Stöhr, Elisabeth, et al.
Publicado: (2020)

Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction
por: Andrié, René P, et al.
Publicado: (2012)

Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis
por: Tillmann, Sabine, et al.
Publicado: (2013)

Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
por: Willecke, Florian, et al.
Publicado: (2011)

Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome
por: Jehle, Julian, et al.
Publicado: (2019)

Prognostic significance of the get with the guidelines-heart failure (GWTG-HF) risk score in patients undergoing trans-catheter tricuspid valve repair (TTVR)
por: Kavsur, Refik, et al.
Publicado: (2021)

Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
por: Tanaka, Tetsu, et al.
Publicado: (2021)

Mitral Regurgitation International Database (MIDA) Score Predicts Outcome in Patients With Heart Failure Undergoing Transcatheter Edge‐to‐Edge Mitral Valve Repair
por: Kavsur, Refik, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
por: Schindler, Christoph, et al.
Publicado: (2014)

Exosomes and Atherogenesis
por: Lin, Bingbing, et al.
Publicado: (2021)

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment
por: Marino, Franca, et al.
Publicado: (2012)

Prognostic Impact of the Get-with-the-Guidelines Heart-Failure Risk Score (GWTG-HF) after Transcatheter Aortic Valve Replacement in Patients with Low-Flow–Low-Gradient Aortic Valve Stenosis
por: Eckel, Clemens, et al.
Publicado: (2023)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE(-/-) mice
por: Jehle, Julian, et al.
Publicado: (2018)

Correction: Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
Publicado: (2014)

Sleep apnoea is common in severe peripheral arterial disease
por: Schahab, Nadjib, et al.
Publicado: (2017)

Receptors | Angiotensin Receptors
por: Pardhi, Triveni R., et al.
Publicado: (2021)

Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice
por: Chen, Shuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gi8fsvhqau0kdaptrmfv716al8